Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Lancet (London, England)|July 19, 2011
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trialJean-Michel Molina, Pedro Cahn, Beatriz Grinsztejn, et al.
The Journal of Antimicrobial Chemotherapy|April 26, 2012
Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trialsMark Nelson, Gerardo Amaya, Nathan Clumeck, et al.
AIDS (London, England)|November 21, 2009
Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trialAnton L Pozniak, Javier Morales-Ramirez, Elly Katabira, et al.
Drugs in R&D|July 12, 2018
Evaluation of Cardiovascular Disease Risk in HIV-1-Infected Patients Treated with DarunavirMagda Opsomer, Dessislava Dimitrova, Johan Verspeelt, et al.
Drugs in R&D|August 7, 2018
Correction to: Evaluation of Cardiovascular Disease Risk in HIV‑1-Infected Patients Treated with DarunavirMagda Opsomer, Dessislava Dimitrova, Johan Verspeelt, et al.
Lancet (London, England)|July 19, 2011
Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trialCalvin J Cohen, Jaime Andrade-Villanueva, Bonaventura Clotet, et al.
AIDS (London, England)|December 14, 2011
Pharmacokinetics and short-term safety and tolerability of etravirine in treatment-experienced HIV-1-infected children and adolescentsChristoph Königs, Cornelia Feiterna-Sperling, Susanna Esposito, et al.
American Journal of Respiratory and Critical Care Medicine|April 19, 2008
Anemia, blood loss, and blood transfusions in North American children in the intensive care unitScot T Bateman, Jacques Lacroix, Katia Boven, et al.
AIDS (London, England)|December 6, 2012
Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trialsCalvin J Cohen, Jean-Michel Molina, Isabel Cassetti, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 21, 2012
Efficacy and safety of rilpivirine (TMC278) versus efavirenz at 48 weeks in treatment-naive HIV-1-infected patients: pooled results from the phase 3 double-blind randomized ECHO and THRIVE TrialsCalvin J Cohen, Jean-Michel Molina, Pedro Cahn, et al.
Pageof 2